- Home
- INM vs TNGX Comparison
INM vs TNGX Comparison
Compare INM & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- TNGX
- Stock Information
- Founded
- INM 1981
- TNGX 2014
- Country
- INM Canada
- TNGX United States
- Employees
- INM N/A
- TNGX N/A
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- TNGX Biotechnology: Pharmaceutical Preparations
- Sector
- INM Health Care
- TNGX Health Care
- Exchange
- INM Nasdaq
- TNGX Nasdaq
- Market Cap
- INM N/A
- TNGX 735.0M
- IPO Year
- INM N/A
- TNGX N/A
- Fundamental
- Price
- INM $0.32
- TNGX $6.64
- Analyst Decision
- INM
- TNGX Strong Buy
- Analyst Count
- INM 0
- TNGX 8
- Target Price
- INM N/A
- TNGX $15.14
- AVG Volume (30 Days)
- INM 581.2K
- TNGX 885.7K
- Earning Date
- INM 11-12-2024
- TNGX 11-06-2024
- Dividend Yield
- INM N/A
- TNGX N/A
- EPS Growth
- INM N/A
- TNGX N/A
- EPS
- INM N/A
- TNGX N/A
- Revenue
- INM $4,597,730.00
- TNGX $42,509,000.00
- Revenue This Year
- INM N/A
- TNGX $18.15
- Revenue Next Year
- INM N/A
- TNGX N/A
- P/E Ratio
- INM N/A
- TNGX N/A
- Revenue Growth
- INM 11.18
- TNGX 26.16
- 52 Week Low
- INM $0.12
- TNGX $6.33
- 52 Week High
- INM $2.08
- TNGX $13.01
- Technical
- Relative Strength Index (RSI)
- INM 70.10
- TNGX 37.15
- Support Level
- INM $0.22
- TNGX $6.83
- Resistance Level
- INM $0.35
- TNGX $7.47
- Average True Range (ATR)
- INM 0.03
- TNGX 0.37
- MACD
- INM 0.01
- TNGX 0.11
- Stochastic Oscillator
- INM 80.38
- TNGX 27.31
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.